Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- VIRO.CO
- Price
- 14.20
- Stock movement down
- -0.55 (-3.73%)
- Company name
- ViroGates A/S
- Exchange
- (CO ,
- Currency
- DKK )
- Sector
- Healthcare >Medical Devices
- Markedsværdi
- 131.80M
- Ent værdi
- 134.06M
- Pris/omsætning
- 16.25
- Pris/bog
- 46.49
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- -
- Efterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -21.44%
- 1 års afkast
- 5.97%
- 3 års afkast
- -
- 5 års afkast
- -
- 10 års afkast
- -
Senest opdateret: 2025-12-12
UDBYTTE
VIRO.CO betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | 16.25 |
| Pris til egenkapital | 46.49 |
| EV i forhold til salg | 16.53 |
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 9.28M |
| EPS (TTM) | - |
| FCF pr. aktie (TTM) | - |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | - |
| Bruttofortjeneste (TTM) | - |
| Driftsindkomst (TTM) | - |
| Nettoindkomst (TTM) | - |
| EPS (TTM) | - |
| EPS (1 år frem) | - |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | - |
| Driftsmargin (TTM) | - |
| Fortjenstmargin (TTM) | - |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 9.12M |
| Nettotilgodehavender | 1.20M |
| Omsætningsaktiver i alt | 14.03M |
| Goodwill | 0.00 |
| Immaterielle aktiver | 0.00 |
| Ejendomme, anlæg og udstyr | 0.00 |
| Sum aktiver | 14.21M |
| Kreditor | 654.00K |
| Kortfristet/nuværende langsigtet gæld | 0.00 |
| Summen af kortfristede forpligtelser | 7.74M |
| Sum gæld | 11.38M |
| Aktionærernes egenkapital | 2.83M |
| Materielle nettoaktiver | 0.00 |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | - |
| Afkast af aktiver | - |
| Afkast af investeret kapital | - |
| Kontant afkast af investeret kapital | - |
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 14.25 |
| Daglig høj | 14.95 |
| Daglig lav | 14.20 |
| Daglig volumen | 2K |
| Højeste gennem alle tider | 238.00 |
| 1 års analytiker estimat | - |
| Beta | 0.95 |
| EPS (TTM) | - |
| Udbytte pr. aktie | 0.00 |
| Ex-div dato | - |
| Næste dato for resultatpræsentation | - |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| VIRO.CO | S&P500 | |
| Nuværende prisfald fra top notering | -94.03% | -1.08% |
| Højeste prisfald | -97.73% | -19.00% |
| Højeste efterår dato | 10 Oct 2024 | 8 Apr 2025 |
| Gennemsnitlig fald fra toppen | -95.53% | -2.64% |
| Gennemsnitlig tid til nyt højdepunkt | - | 6 days |
| Maks. tid til nyt højdepunkt | 296 days | 89 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
131.80M
Markedsværdi kategori
Small-cap
Beskrivelse
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer. The company's product includes suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the soluble urokinase plasminogen activator receptor (suPAR) level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic ELISA that provides fully quantitative results; and suPARnostic Quick Triage kit for use in the point of care situation for early warning and patient triaging that allows clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression, and outcome. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.
Personale
7
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Denmark
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Institutional Investor Converts Warrants, Injecting $595,000 to Accelerate Nextech3D.ai's Blockchain Ticketing Rollout and Event Token Ecosystem NEW YORK CITY, NY AND TORONTO, ON / ACCESS Newswire / O...
7. oktober 2025
All-cash purchase price of approximately $700,000; Eventdex serves 60+ customers; generated ~$750K in 2024 revenue and ~$500K year-to-date 2025. Combination unifies Map D's floor mapping with Eventdex...
30. september 2025
New high-margin, pure profit revenue stream for Nextech3D.ai. NEW YORK, NY AND TORONTO, ON / ACCESS Newswire / September 3, 2025 / Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), a leading provider of ...
3. september 2025
It's the ultimate convergence of AI, AR, mobile, and crypto - built for the future of live experiences NEW YORK, NY AND TORONTO, ON / ACCESS Newswire / July 24, 2025 /Nextech3D.ai (OTCQB:NEXCF)(CSE:NT...
24. juli 2025
Collaboration Leverages AI to Deliver Cost-Effective, Scalable 3D Product Visualization TORONTO, ON / ACCESS Newswire / March 6, 2025 / Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), a leader in AI-po...
6. marts 2025
TORONTO, ON / ACCESS Newswire / January 17, 2025 / Nextech3D.AI (OTCQX:NEXCF)(CSE:NTAR)(FSE:EP2), established in 2018, has been a pioneer in augmented reality (AR) and artificial intelligence (AI) tec...
17. januar 2025